DOI QR코드

DOI QR Code

Relationship Between Plasma Adiponectin, Retinol-Binding Protein 4 and Uric Acid in Hypertensive Patients With Metabolic Syndrome

  • Park, Chan-Seok (Department of Cardiology, College of Medicine, The Catholic University of Korea, Bucheon St. Mary' Hospital) ;
  • Ihm, Sang-Hyun (Department of Cardiology, College of Medicine, The Catholic University of Korea, Bucheon St. Mary' Hospital) ;
  • Park, Hun-Jun (Department of Cardiology, College of Medicine, The Catholic University of Korea, Bucheon St. Mary' Hospital) ;
  • Shin, Woo-Seung (Department of Cardiology, College of Medicine, The Catholic University of Korea, Bucheon St. Mary' Hospital) ;
  • Kim, Pum-Jun (Department of Cardiology, College of Medicine, The Catholic University of Korea, Bucheon St. Mary' Hospital) ;
  • Chang, Ki-Yuk (Department of Cardiology, College of Medicine, The Catholic University of Korea, Bucheon St. Mary' Hospital) ;
  • Kim, Hee-Yeol (Department of Cardiology, College of Medicine, The Catholic University of Korea, Bucheon St. Mary' Hospital) ;
  • Youn, Ho-Joong (Department of Cardiology, College of Medicine, The Catholic University of Korea, Bucheon St. Mary' Hospital) ;
  • Chung, Wook-Sung (Department of Cardiology, College of Medicine, The Catholic University of Korea, Bucheon St. Mary' Hospital) ;
  • Seung, Ki-Bae (Department of Cardiology, College of Medicine, The Catholic University of Korea, Bucheon St. Mary' Hospital) ;
  • Kim, Jae-Hyung (Department of Cardiology, College of Medicine, The Catholic University of Korea, Bucheon St. Mary' Hospital)
  • 발행 : 2011.04.30

초록

Background and Objectives: Adipokines have been suggested for their potential use in tracking the clinical progress in the subjects with metabolic syndrome (MS). To investigate the relationship between the serum levels of adipokines {adiponectin and retinol-binding protein 4 (RBP4)} and the serum level of uric acid in hypertensive (HTN) patients with MS. Subjects and Methods: In this study, 38 totally untreated HTN patients were enrolled. Anthropometric measurements, blood pressure (BP) were taken in the 12 HTN patients without MS and the 26 HTN patients with MS. Fasting blood samples were collected for measurement of adiponectin, RBP4, nitric oxide (NO), glucose, creatinine, uric acid, lipid profile and insulin. Results: The HTN with MS group had significant higher values of body mass index, waist length, serum uric acid and triglyceride levels than the HTN without MS group. Compared to the HTN without MS group, the HTN with MS group showed significantly lower adiponectin (p=0.030), NO (p=0.003) and high density lipoprotein levels (p<0.001). Serum adiponectin levels negatively correlated with insulin level (R=-0.453, p=0.026) and uric acid level (R=-0.413, p=0.036), and serum RBP4 levels positively correlated with uric acid level (R=0.527, p=0.006) in the HTN with MS group. Multiple linear regression analysis using RBP4 and adiponectin levels as the dependent variables showed that uric acid level correlated with serum RBP4 level (p=0.046) and adiponectin level (p=0.044). Conclusion: The HTN with MS group showed a correlation with two types of adipokines (adiponectin, RBP4) and uric acid. Adiponectin, RBP4 and uric acid may be important components associated with MS, especially when associated with hypertension.

키워드

참고문헌

  1. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an America Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52. https://doi.org/10.1161/CIRCULATIONAHA.105.169404
  2. Cuspidi C, Meani S, Valerio C, et al. Age and target organ damage in essential hypertension: role of the metabolic syndrome. Am J Hypertens 2007;20:296-303. https://doi.org/10.1016/j.amjhyper.2006.09.010
  3. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16. https://doi.org/10.1001/jama.288.21.2709
  4. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamamoto M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 2005; 25:1038-44. https://doi.org/10.1161/01.ATV.0000161274.87407.26
  5. Coutinho Tde A, Turner ST, Peyser PA, Bielak LF, Sheedy PF 2nd, Kullo IJ. Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens 2007;20:83-9. https://doi.org/10.1016/j.amjhyper.2006.06.015
  6. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999;131:7-13. https://doi.org/10.7326/0003-4819-131-1-199907060-00003
  7. Ouchi N, Kihara S, Arita Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001;103:1057-63. https://doi.org/10.1161/01.CIR.103.8.1057
  8. Yang WS, Lee WJ, Funahashi T, et al. Plasma adiponectin levels in overweight and obese Asians. Obes Res 2002;10:1104-10. https://doi.org/10.1038/oby.2002.150
  9. Graham TE, Yang Q, Bluher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552-63. https://doi.org/10.1056/NEJMoa054862
  10. Balletshofer BM, Rittig K, Enderle MD, et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 2000;101:1780-4. https://doi.org/10.1161/01.CIR.101.15.1780
  11. Alberti KG, Zimmet P, Shaw J, et al. The metabolic syndrome-a new worldwide definition. Lancet 2005;366:1059-62. https://doi.org/10.1016/S0140-6736(05)67402-8
  12. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity ch-eck index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10. https://doi.org/10.1210/jc.85.7.2402
  13. Hong SP, Lee YS, Bae KR, et al. Relationship between serum uric acid level and metabolic syndrome according to gender. Korean Circ J 2008;38:152-60. https://doi.org/10.4070/kcj.2008.38.3.152
  14. Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991;266: 3008-11. https://doi.org/10.1001/jama.1991.03470210076036
  15. Yoo TW, Sung KC, Kim YC, et al. The relationship of the hypertension, insulin resistance, and metabolic syndrome in the serum uric acid level. Korean Circ J 2004;34:874-82.
  16. Chen CC, Wu JY, Chang CT, et al. Levels of retinol-binding 4 and uric acid in patients with type 2 diabetes mellitus. Metabolism 2009;58: 1812-6. https://doi.org/10.1016/j.metabol.2009.06.013
  17. Ingelsson E, Sundstrom J, Melhbus H, et al. Circulating retinol binding 4, cardiovascular risk factors and prevent cardiovascular disease in elderly. Atherosclerosis 2009;206:239-44. https://doi.org/10.1016/j.atherosclerosis.2009.02.029
  18. Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism 2006;55:1551-7. https://doi.org/10.1016/j.metabol.2006.06.028

피인용 문헌

  1. Uric acid upregulates the adiponectin-adiponectin receptor 1 pathway in renal proximal tubule epithelial cells vol.17, pp.3, 2018, https://doi.org/10.3892/mmr.2017.8315
  2. Components of metabolic syndrome in relation to plasma levels of retinol binding protein 4 (RBP4) in a cohort of people aged 65 years and older vol.41, pp.10, 2011, https://doi.org/10.1007/s40618-018-0856-6